Dianne Fishwild

Dr. Fishwild has more than 25 years of experience in assay development, qualification and validation. She has held positions of increasing responsibility from Scientist to Senior Director at Cutter Biologics, Xoma Corporation, GenPharm International, Affymax Research Institute, Guava Technologies, Geron and Asterias Biotherapeutics. Dr. Fishwild is a dynamic scientific leader with extensive experience in R&D and GMP assay development for cell-based, biological and small molecule drugs. Her primary focus has been on cell-based assays such as flow cytometry, immunocytochemistry, proliferation and immune function, but she is adept at ELISA and qPCR assays among others. Dr. Fishwild has successfully launched assays and products that met specifications and design control requirements, participated in regulatory aspects of drug development as well as development of an IVD product, and wrote and reviewed documentation for product manufacture, product testing and customer support. She received her BS in Chemistry from the University of Colorado at Denver and her PhD in Biochemistry from the University of Colorado Health Sciences Center.